Personalized medicine in sepsis: The coming of age
| dc.contributor.author | Christaki, Eirini | en |
| dc.creator | Christaki, Eirini | en |
| dc.date.accessioned | 2018-06-22T09:52:49Z | |
| dc.date.available | 2018-06-22T09:52:49Z | |
| dc.date.issued | 2013 | |
| dc.identifier.uri | https://gnosis.library.ucy.ac.cy/handle/7/41525 | |
| dc.description.abstract | "a there is both the need to discover specific and clinically useful biomarkers in order to diagnose sepsis, define the hosta s immune status, monitor treatment and define prognosis and to develop medications that would target the disease profile of each patient." © 2013 Informa UK Ltd. | en |
| dc.language.iso | eng | en |
| dc.source | Expert Review of Anti-Infective Therapy | en |
| dc.subject | Human | en |
| dc.subject | Prognosis | en |
| dc.subject | Drug efficacy | en |
| dc.subject | Sepsis | en |
| dc.subject | Genetic association | en |
| dc.subject | Single nucleotide polymorphism | en |
| dc.subject | Hepatitis c | en |
| dc.subject | Patient monitoring | en |
| dc.subject | Biological marker | en |
| dc.subject | Blood sampling | en |
| dc.subject | Disease predisposition | en |
| dc.subject | Afelimomab | en |
| dc.subject | Blood culture | en |
| dc.subject | Cd64 antigen | en |
| dc.subject | Diagnostic accuracy | en |
| dc.subject | Early diagnosis | en |
| dc.subject | Editorial | en |
| dc.subject | Functional proteomics | en |
| dc.subject | Functional status | en |
| dc.subject | Gene expression | en |
| dc.subject | Genomics | en |
| dc.subject | Host pathogen interaction | en |
| dc.subject | Immune status | en |
| dc.subject | Immunoregulation | en |
| dc.subject | Individualized medicine | en |
| dc.subject | Infection risk | en |
| dc.subject | Metabolomics | en |
| dc.subject | Microarray analysis | en |
| dc.subject | Multiplex polymerase chain reaction | en |
| dc.subject | Peginterferon | en |
| dc.subject | Personalized medicine | en |
| dc.subject | Proadrenomedullin | en |
| dc.subject | Ribavirin | en |
| dc.subject | Septic shock | en |
| dc.subject | Transcriptomics | en |
| dc.subject | Triggering receptor expressed on myeloid cells 1 | en |
| dc.title | Personalized medicine in sepsis: The coming of age | en |
| dc.type | info:eu-repo/semantics/article | |
| dc.identifier.doi | 10.1586/14787210.2013.811845 | |
| dc.description.volume | 11 | |
| dc.description.issue | 7 | |
| dc.description.startingpage | 645 | |
| dc.description.endingpage | 647 | |
| dc.author.faculty | Ιατρική Σχολή / Medical School | |
| dc.author.department | Ιατρική Σχολή / Medical School | |
| dc.type.uhtype | Article | en |
| dc.contributor.orcid | Christaki, Eirini [0000-0002-8152-6367] | |
| dc.gnosis.orcid | 0000-0002-8152-6367 |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||